Avoiding Study Bias in Long-Term and Intermediate Stability Data
Avoiding Study Bias in Long-Term and Intermediate Stability Data Preventing Bias in Long-Term and Intermediate Stability Studies: Safeguarding Data Integrity and Compliance Bias in pharmaceutical stability studies can subtly compromise the validity of shelf-life justification and product quality assessments. Whether intentional or unintentional, study bias—manifesting as selective data reporting, analytical inconsistencies, or misinterpretation—can lead to…
Read More “Avoiding Study Bias in Long-Term and Intermediate Stability Data” »